108 related articles for article (PubMed ID: 25838370)
21. [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ; Guo KY; Wei HM; Song CY
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):887-9. PubMed ID: 17584663
[TBL] [Abstract][Full Text] [Related]
22. Four novel ULBP splice variants are ligands for human NKG2D.
Cao W; Xi X; Wang Z; Dong L; Hao Z; Cui L; Ma C; He W
Int Immunol; 2008 Aug; 20(8):981-91. PubMed ID: 18544572
[TBL] [Abstract][Full Text] [Related]
23. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
24. Susceptibility of CD24(+) ovarian cancer cells to anti-cancer drugs and natural killer cells.
Koh J; Lee SB; Park H; Lee HJ; Cho NH; Kim J
Biochem Biophys Res Commun; 2012 Oct; 427(2):373-8. PubMed ID: 22995296
[TBL] [Abstract][Full Text] [Related]
25. Sodium butyrate upregulates expression of NKG2D ligand MICA/B in HeLa and HepG2 cell lines and increases their susceptibility to NK lysis.
Zhang C; Wang Y; Zhou Z; Zhang J; Tian Z
Cancer Immunol Immunother; 2009 Aug; 58(8):1275-85. PubMed ID: 19139882
[TBL] [Abstract][Full Text] [Related]
26. NKG2D and its ligands.
Obeidy P; Sharland AF
Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
[TBL] [Abstract][Full Text] [Related]
27. Importance of NKG2D-NKG2D ligands interaction for cytolytic activity of natural killer cell.
Bae DS; Hwang YK; Lee JK
Cell Immunol; 2012; 276(1-2):122-7. PubMed ID: 22613008
[TBL] [Abstract][Full Text] [Related]
28. Advances in NKG2D ligand recognition and responses by NK cells.
Le Bert N; Gasser S
Immunol Cell Biol; 2014 Mar; 92(3):230-6. PubMed ID: 24445601
[TBL] [Abstract][Full Text] [Related]
29. Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
Brando C; Mukhopadhyay S; Kovacs E; Medina R; Patel P; Catina TL; Campbell KS; Santoli D
J Leukoc Biol; 2005 Aug; 78(2):359-71. PubMed ID: 15937142
[TBL] [Abstract][Full Text] [Related]
30. Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules.
Held W; Chalifour A; Coudert JD
Med Microbiol Immunol; 2005 Aug; 194(4):169-74. PubMed ID: 15660246
[No Abstract] [Full Text] [Related]
31. c-Cbl regulates MICA- but not ULBP2-induced NKG2D down-modulation in human NK cells.
Molfetta R; Quatrini L; Capuano C; Gasparrini F; Zitti B; Zingoni A; Galandrini R; Santoni A; Paolini R
Eur J Immunol; 2014 Sep; 44(9):2761-70. PubMed ID: 24846123
[TBL] [Abstract][Full Text] [Related]
32. [Methodology in innate immunity to viral HCC].
Goto K; Kato N
Nihon Rinsho; 2015 Dec; 73 Suppl 9():419-23. PubMed ID: 26845970
[No Abstract] [Full Text] [Related]
33. Editorial: Emerging Concepts on the NKG2D Receptor-Ligand Axis in Health and Diseases.
Guerra N; Lanier LL
Front Immunol; 2020; 11():562. PubMed ID: 32318064
[No Abstract] [Full Text] [Related]
34. Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers.
Wu L; Parton A; Lu L; Adams M; Schafer P; Bartlett JB
Cancer Immunol Immunother; 2011 Jan; 60(1):61-73. PubMed ID: 20848094
[TBL] [Abstract][Full Text] [Related]
35. Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns.
Haik J; Nardini G; Goldman N; Galore-Haskel G; Harats M; Zilinsky I; Weissman O; Schachter J; Winkler E; Markel G
Oncotarget; 2016 Jan; 7(3):2220-8. PubMed ID: 26745675
[TBL] [Abstract][Full Text] [Related]
36. Expression Profiles of Ligands for Activating Natural Killer Cell Receptors on HIV Infected and Uninfected CD4⁺ T Cells.
Tremblay-McLean A; Bruneau J; Lebouché B; Lisovsky I; Song R; Bernard NF
Viruses; 2017 Oct; 9(10):. PubMed ID: 29023371
[TBL] [Abstract][Full Text] [Related]
37. Ly49 family receptors are required for cancer immunosurveillance mediated by natural killer cells.
Tu MM; Mahmoud AB; Wight A; Mottashed A; Bélanger S; Rahim MM; Abou-Samra E; Makrigiannis AP
Cancer Res; 2014 Jul; 74(14):3684-94. PubMed ID: 24802191
[TBL] [Abstract][Full Text] [Related]
38. A role for the src family kinase Fyn in NK cell activation and the formation of the repertoire of Ly49 receptors.
Lowin-Kropf B; Kunz B; Schneider P; Held W
Eur J Immunol; 2002 Mar; 32(3):773-82. PubMed ID: 11870621
[TBL] [Abstract][Full Text] [Related]
39. Upregulated mRNA expression of major histocompatibility complex class I chain-related gene A in colon and activated natural killer cells of Chinese patients with ulcerative colitis.
Ge LQ; Jiang T; Zhao J; Chen ZT; Zhou F; Xia B
J Dig Dis; 2011 Apr; 12(2):82-9. PubMed ID: 21091928
[TBL] [Abstract][Full Text] [Related]
40. UL16 binding proteins.
Cao W; He W
Immunobiology; 2004; 209(3):283-90. PubMed ID: 15518340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]